<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ANormalized_own_funds_generation</id>
	<title>Definition:Normalized own funds generation - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ANormalized_own_funds_generation"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Normalized_own_funds_generation&amp;action=history"/>
	<updated>2026-06-13T21:11:34Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Normalized_own_funds_generation&amp;diff=12237&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Normalized_own_funds_generation&amp;diff=12237&amp;oldid=prev"/>
		<updated>2026-03-12T09:57:30Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏦 &amp;#039;&amp;#039;&amp;#039;Normalized own funds generation&amp;#039;&amp;#039;&amp;#039; refers to the recurring, underlying increase in an insurer&amp;#039;s [[Definition:Own funds | own funds]] — the regulatory measure of available capital — after stripping out volatile, non-recurring, or market-driven items that can obscure the true earnings power of the business. In [[Definition:Solvency II | Solvency II]] jurisdictions across Europe, own funds represent the capital resources available to cover the [[Definition:Solvency capital requirement (SCR) | solvency capital requirement]], and normalized generation isolates the portion of that capital growth attributable to the insurer&amp;#039;s ongoing operations rather than to fluctuations in interest rates, equity markets, model changes, or one-off transactions. Large European groups such as those headquartered in France, Germany, Italy, and the Netherlands routinely present this metric to give analysts a cleaner view of sustainable capital creation.&lt;br /&gt;
&lt;br /&gt;
⚙️ To arrive at the normalized figure, insurers typically begin with the total change in own funds over a period, then adjust for items considered non-operational: mark-to-market movements on [[Definition:Investment portfolio | investment portfolios]], changes in [[Definition:Risk margin | risk margin]] assumptions, [[Definition:Regulatory | regulatory]] model updates, [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]] effects, and the impact of [[Definition:Dividend | dividends]] or [[Definition:Share buyback | share buybacks]] already paid out. What remains is intended to reflect the capital generated by [[Definition:Underwriting | underwriting]] profits, the unwinding of the [[Definition:Discount rate | discount rate]] on [[Definition:Reserves | reserves]], expected investment returns, and the release of margins on [[Definition:In-force business | in-force business]]. Because Solvency II own funds are a market-consistent balance-sheet concept, the normalization process requires considerable judgment, and disclosures vary across firms — making peer comparison an exercise that demands careful reading of methodology notes.&lt;br /&gt;
&lt;br /&gt;
💡 Investors value this metric because it bridges the gap between volatile statutory results and the sustainable cash-generating capacity of an insurance group. A company may report a sharp decline in raw own funds in a quarter when credit spreads widen, yet its normalized generation could remain stable, indicating that the core business continues to perform. This distinction matters enormously for evaluating [[Definition:Payout ratio | payout ratios]], [[Definition:Organic capital generation | organic capital generation]] targets, and the insurer&amp;#039;s ability to fund [[Definition:Dividend | dividends]] and growth without external capital raises. As [[Definition:IFRS 17 | IFRS 17]] reshapes how profits are recognized in insurance, normalized own funds generation serves as a vital regulatory-capital-side complement to accounting earnings, particularly for groups that must manage capital across multiple regimes simultaneously.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Own funds]]&lt;br /&gt;
* [[Definition:Solvency capital requirement (SCR)]]&lt;br /&gt;
* [[Definition:Organic capital generation]]&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
* [[Definition:Operating return]]&lt;br /&gt;
* [[Definition:Payout ratio]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>